![An In Depth Review Of Cbd Gummies Relax Nanocraftcbd [OLeO1jbOoaI]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-8670032-150x150.jpg "An In Depth Review Of Cbd Gummies Relax Nanocraftcbd [OLeO1jbOoaI] 9")
![B+cbd Gummies For Metabolic Balance And Daily Wellness [3s5LqrrZ748]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-3259579-150x150.jpg "B+cbd Gummies For Metabolic Balance And Daily Wellness [3s5LqrrZ748] 11")
Medical Cannabis Evidence-Based Care: CBD Autism RCT
This CBD autism clinical trial investigated oral CBD oil effects on social behavior, anxiety, and parental stress in autistic children. The randomized controlled crossover design provided rigorous evidence. Results suggest potential benefits of CBD in…
Cannabinoids in Pediatric Medicine: Evidence-Based Review
Cannabinoid clinical trials pediatric research provides evolving evidence on safety and efficacy in children. This review highlights cautious clinical consideration where conventional treatments fall short. Ongoing studies continue to inform best…
Daily Digest 2026-03-06
✦ New Top items from the CED news pipeline. (82) Scientists are raising new concerns about marijuana use in teens – KPBSResearch continues to build a concerning picture around adolescent cannabis use and its association with elevated risk…
In the Mix: 3 More Articles — March 05, 2026
The cannabis tax revenue decline in Michigan highlights shifting market dynamics affecting recreational cannabis sales. This trend signals changes in consumer behavior and regulatory impacts. Understanding cannabis tax revenue decline is crucial for…
Daily Digest: Last 9 Hours: Cognitive Safety Data, End-of-Life Access, and Regulatory Friction — March 05, 2026
This digest highlights recent research on cognitive safety in older adults using cannabis, addressing dementia risk and clinical implications. It also covers advances in end-of-life cannabis access and ongoing regulatory friction. These insights provide…
Daily Digest: Cannabis Impact on Adolescent Brain in 2026
2026 cannabis adolescent brain vulnerability is a growing concern among researchers. Studies link teen cannabis use to increased psychiatric risks such as psychosis and depression. Understanding these risks is critical for public health and clinical…
Cannabinoids in Pediatric Care: Evidence-Based Clinical Review
Cannabinoid use in children is an evolving area with limited rigorous evidence. Most data comes from observational studies rather than controlled trials. This review highlights the current clinical evidence and safety considerations for cannabinoids in…
CED Cannabis Research Digest — February 27, 2026
The cannabis medicine research digest for February 27, 2026, highlights key peer-reviewed studies scored for clinical relevance. This weekly digest provides a curated summary of cannabis research to inform patient care. Stay updated with the latest…
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
NHS access barriers medical cannabis remain a critical issue for pediatric drug-resistant epilepsy patients in the UK. Despite legal changes, many children cannot access cannabinoid therapies through the NHS. This campaign highlights the urgent need for…
Daily Digest: Last 19 Hours: Aging Brains, Adolescent Risk, and the Slow March of Policy Reform — March 04, 2026
This digest reviews recent findings on cannabis and cognitive aging, highlighting reassuring safety data for older adults. It also addresses adolescent cannabis exposure risks and ongoing policy reform challenges. The focus on cannabis and cognitive…